Terms: = Colorectal cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED
95 results:
1. SIRT6 Inhibits Anoikis of colorectal cancer Cells by Down-Regulating NDRG1.
Li F; Yu W; Zhou X; Hou J; Gao Y; Zhang J; Gao X
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891773
[TBL] [Abstract] [Full Text] [Related]
2. CKLF instigates a "cold" microenvironment to promote mycn-mediated tumor aggressiveness.
Qin X; Lam A; Zhang X; Sengupta S; Iorgulescu JB; Ni H; Das S; Rager M; Zhou Z; Zuo T; Meara GK; Floru AE; Kemet C; Veerapaneni D; Kashy D; Lin L; Lloyd K; Kwok L; Smith KS; Nagaraju RT; Meijers R; Ceol C; Liu CT; Alexandrescu S; Wu CJ; Keskin DB; George RE; Feng H
Sci Adv; 2024 Mar; 10(11):eadh9547. PubMed ID: 38489372
[TBL] [Abstract] [Full Text] [Related]
3. First-line Palliative Chemotherapy for colorectal cancer: a Population-based Analysis of Delivery and Outcomes in a Single-payer Health System.
Wilson BE; Booth CM; Patel S; Berry S; Kong W; Merchant SJ
Clin Oncol (R Coll Radiol); 2024 Apr; 36(4):211-220. PubMed ID: 38199907
[TBL] [Abstract] [Full Text] [Related]
4. RPF2 mediates the CARM1‑mycn axis to promote chemotherapy resistance in colorectal cancer cells.
Lu M; Hu X; Cheng C; Zhang Y; Huang L; Kong X; Li Z; Zhang Q; Zhang Y
Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37997821
[TBL] [Abstract] [Full Text] [Related]
5. Antitumor Activity of Piceamycin by Upregulation of n-myc Downstream-Regulated Gene 1 in Human colorectal cancer Cells.
Kyaw KZ; Byun WS; Shin YH; Huynh TH; Lee JY; Bae ES; Park HJ; Oh DC; Lee SK
J Nat Prod; 2022 Dec; 85(12):2817-2827. PubMed ID: 36458922
[TBL] [Abstract] [Full Text] [Related]
6. Effect of radical lymphadenectomy in colorectal cancer with para-aortic lymph node metastasis: a systematic review and meta-analysis.
Zhao P; Yang X; Yan Y; Yang J; Li S; Du X
BMC Surg; 2022 May; 22(1):181. PubMed ID: 35568938
[TBL] [Abstract] [Full Text] [Related]
7. Claudin-2 promotes colorectal cancer growth and metastasis by suppressing NDRG1 transcription.
Wei M; Zhang Y; Yang X; Ma P; Li Y; Wu Y; Chen X; Deng X; Yang T; Mao X; Qiu L; Meng W; Zhang B; Wang Z; Han J
Clin Transl Med; 2021 Dec; 11(12):e667. PubMed ID: 34965023
[TBL] [Abstract] [Full Text] [Related]
8. NDRG1 enhances the sensitivity of cetuximab by modulating EGFR trafficking in colorectal cancer.
Yang G; Huang L; Jia H; Aikemu B; Zhang S; Shao Y; Hong H; Yesseyeva G; Wang C; Li S; Sun J; Zheng M; Ma J
Oncogene; 2021 Oct; 40(41):5993-6006. PubMed ID: 34385595
[TBL] [Abstract] [Full Text] [Related]
9. NDRG1 regulates Filopodia-induced colorectal cancer invasiveness via modulating CDC42 activity.
Aikemu B; Shao Y; Yang G; Ma J; Zhang S; Yang X; Hong H; Yesseyeva G; Huang L; Jia H; Wang C; Zang L; Sun J; Zheng M
Int J Biol Sci; 2021; 17(7):1716-1730. PubMed ID: 33994856
[TBL] [Abstract] [Full Text] [Related]
10. Loss of enteric neuronal Ndrg4 promotes colorectal cancer via increased release of Nid1 and Fbln2.
Vaes N; Schonkeren SL; Rademakers G; Holland AM; Koch A; Gijbels MJ; Keulers TG; de Wit M; Moonen L; Van der Meer JRM; van den Boezem E; Wolfs TGAM; Threadgill DW; Demmers J; Fijneman RJA; Jimenez CR; Vanden Berghe P; Smits KM; Rouschop KMA; Boesmans W; Hofstra RMW; Melotte V
EMBO Rep; 2021 Jun; 22(6):e51913. PubMed ID: 33890711
[TBL] [Abstract] [Full Text] [Related]
11. LncRNA RAD51-AS1/miR-29b/c-3p/NDRG2 crosstalk repressed proliferation, invasion and glycolysis of colorectal cancer.
Li C; Wang P; Du J; Chen J; Liu W; Ye K
IUBMB Life; 2021 Jan; 73(1):286-298. PubMed ID: 33314669
[TBL] [Abstract] [Full Text] [Related]
12. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
Naderi A
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
[TBL] [Abstract] [Full Text] [Related]
13. DERL3 suppresses colorectal cancer metastasis through negatively regulating mycn level.
Yu F; Mou B; Sheng J; Liu J; Qin X; Yu J
Minerva Med; 2023 Jun; 114(3):316-322. PubMed ID: 32538588
[TBL] [Abstract] [Full Text] [Related]
14. Thymidylate synthase inhibitor raltitrexed can induce high levels of DNA damage in mycn-amplified neuroblastoma cells.
Yamashita K; Kiyonari S; Tsubota S; Kishida S; Sakai R; Kadomatsu K
Cancer Sci; 2020 Jul; 111(7):2431-2439. PubMed ID: 32415892
[TBL] [Abstract] [Full Text] [Related]
15. n-myc downstream-regulated gene 1 inhibits the proliferation of colorectal cancer through emulative antagonizing NEDD4-mediated ubiquitylation of p21.
Zhang S; Yu C; Yang X; Hong H; Lu J; Hu W; Hao X; Li S; Aikemu B; Yang G; He Z; Zhang L; Xue P; Cai Z; Ma J; Zang L; Feng B; Yuan F; Sun J; Zheng M
J Exp Clin Cancer Res; 2019 Dec; 38(1):490. PubMed ID: 31831018
[TBL] [Abstract] [Full Text] [Related]
16. NMI promotes cell proliferation through TGFβ/Smad pathway by upregulating STAT1 in colorectal cancer.
Ji D; Feng Y; Peng W; Li J; Gu Q; Zhang Z; Qian W; Wang Q; Zhang Y; Sun Y
J Cell Physiol; 2020 Jan; 235(1):429-441. PubMed ID: 31230364
[TBL] [Abstract] [Full Text] [Related]
17. Emerging Roles of C-Myc in cancer Stem Cell-Related Signaling and Resistance to cancer Chemotherapy: A Potential Therapeutic Target Against colorectal cancer.
Elbadawy M; Usui T; Yamawaki H; Sasaki K
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31083525
[TBL] [Abstract] [Full Text] [Related]
18. Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling.
Iniguez AB; Alexe G; Wang EJ; Roti G; Patel S; Chen L; Kitara S; Conway A; Robichaud AL; Stolte B; Bandopadhayay P; Goodale A; Pantel S; Lee Y; Cheff DM; Hall MD; Guha R; Davis MI; Menard M; Nasholm N; Weiss WA; Qi J; Beroukhim R; Piccioni F; Johannessen C; Stegmaier K
Cancer Cell; 2018 Dec; 34(6):922-938.e7. PubMed ID: 30537514
[TBL] [Abstract] [Full Text] [Related]
19. The prognostic value of decreased NDRG1 expression in patients with digestive system cancers: A meta-analysis.
Chen K; Liu XH; Wang FR; Liu HP; Huang ZP; Chen X
Medicine (Baltimore); 2018 Oct; 97(41):e12455. PubMed ID: 30313035
[TBL] [Abstract] [Full Text] [Related]
20. Identification of high-risk human papillomavirus and Rb/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma.
Shamir ER; Devine WP; Pekmezci M; Umetsu SE; Krings G; Federman S; Cho SJ; Saunders TA; Jen KY; Bergsland E; Jones K; Kim GE; Kakar S; Chiu CY; Joseph NM
Mod Pathol; 2019 Feb; 32(2):290-305. PubMed ID: 30237525
[TBL] [Abstract] [Full Text] [Related]
[Next]
